[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock",
    "section": "",
    "text": "Reference Studies:\n\nMahmoud et al., 2018\n\nStudy Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults patients hospitalized with acute myocardial infarction complicated by cardiogenic shock using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its associations with in-hospital mortality, length of stay (LOS), and hospital charges.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nPatients aged ≤18 years\nPrincipal diagnosis of acute myocardial infarction using ICD code I21 and secondary diagnosis of cardiogenic shock using ICD code R570\nNon-elective admission\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nBinary indicator of 30-day readmission (Yes/No)\n\nSecondary Outcomes:\n\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using NRD’s linkage variables. Readmissions were identified only among patients with qualifying index events.\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCharge:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\n\nCovariates:\n\nDemographic & Socioeconomic Factors:\n\nAge\nSex\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nZIP-based median income quartile\n\nClinical Characteristics:\n\nNumber of comorbidities\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nDischarge disposition\nLength of stay (categorized as above)\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses incorporated NRD’s complex sampling design via the survey and srvyr packages.\n\nDescriptive Statistics:\n\nWeighted baseline characteristics of index hospitalizations were summarized and stratified by 30-day readmission status to compare patients who were readmitted versus those who were not.\nStratification was performed using a derived binary variable, which categorized patients as:\n\nWith 30-day readmission\nWithout readmission\n\nP-values from statistical tests (Rao–Scott adjusted chi-square for categorical variables; Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock",
    "section": "",
    "text": "Reference Studies:\n\nMahmoud et al., 2018\n\nStudy Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults patients hospitalized with acute myocardial infarction complicated by cardiogenic shock using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its associations with in-hospital mortality, length of stay (LOS), and hospital charges.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nPatients aged ≤18 years\nPrincipal diagnosis of acute myocardial infarction using ICD code I21 and secondary diagnosis of cardiogenic shock using ICD code R570\nNon-elective admission\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nBinary indicator of 30-day readmission (Yes/No)\n\nSecondary Outcomes:\n\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using NRD’s linkage variables. Readmissions were identified only among patients with qualifying index events.\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCharge:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\n\nCovariates:\n\nDemographic & Socioeconomic Factors:\n\nAge\nSex\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nZIP-based median income quartile\n\nClinical Characteristics:\n\nNumber of comorbidities\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nDischarge disposition\nLength of stay (categorized as above)\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses incorporated NRD’s complex sampling design via the survey and srvyr packages.\n\nDescriptive Statistics:\n\nWeighted baseline characteristics of index hospitalizations were summarized and stratified by 30-day readmission status to compare patients who were readmitted versus those who were not.\nStratification was performed using a derived binary variable, which categorized patients as:\n\nWith 30-day readmission\nWithout readmission\n\nP-values from statistical tests (Rao–Scott adjusted chi-square for categorical variables; Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#descriptive-statistics",
    "href": "quarto/index.html#descriptive-statistics",
    "title": "Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock",
    "section": "Descriptive Statistics:",
    "text": "Descriptive Statistics:\n\nReadmission Rate:\n\n\nBaseline Characteristics\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 22,7791\nWithout Readmission\nN = 21,6751\nWith 30-day readmission\nN = 1,1041\np-value2\n\n\n\n\nAge (years)\n\n\n\n\n\n\n0.3\n\n\n    18–49\n1,596 (7.0%)\n1,522 (7.0%)\n74 (6.7%)\n\n\n\n\n    50–64\n6,893 (30%)\n6,590 (30%)\n303 (27%)\n\n\n\n\n    65–79\n9,391 (41%)\n8,890 (41%)\n501 (45%)\n\n\n\n\n    80+\n4,899 (22%)\n4,672 (22%)\n226 (20%)\n\n\n\n\nSex\n\n\n\n\n\n\n0.10\n\n\n    Male\n14,712 (65%)\n14,039 (65%)\n673 (61%)\n\n\n\n\n    Female\n8,067 (35%)\n7,636 (35%)\n431 (39%)\n\n\n\n\nMedian Income Quartile\n\n\n\n\n\n\n0.3\n\n\n    0-25th percentile\n6,549 (29%)\n6,205 (29%)\n344 (32%)\n\n\n\n\n    26th to 50th percentile\n6,597 (29%)\n6,272 (29%)\n324 (30%)\n\n\n\n\n    51st to 75th percentile\n5,444 (24%)\n5,218 (24%)\n226 (21%)\n\n\n\n\n    76th to 100th percentile\n3,818 (17%)\n3,626 (17%)\n192 (18%)\n\n\n\n\nHospital Bed Size\n\n\n\n\n\n\n0.6\n\n\n    Small\n2,285 (10%)\n2,162 (10.0%)\n123 (11%)\n\n\n\n\n    Large\n14,531 (64%)\n13,848 (64%)\n682 (62%)\n\n\n\n\n    Medium\n5,963 (26%)\n5,664 (26%)\n299 (27%)\n\n\n\n\nHospital Urbanization\n\n\n\n\n\n\n0.2\n\n\n    Large metropolitan ≥1 million\n11,973 (53%)\n11,346 (52%)\n628 (57%)\n\n\n\n\n    Micropolitan\n1,063 (4.7%)\n1,008 (4.7%)\n55 (5.0%)\n\n\n\n\n    Non-urban\n80 (0.4%)\n78 (0.4%)\n2 (0.2%)\n\n\n\n\n    Small metropolitan &lt;1 million\n9,662 (42%)\n9,243 (43%)\n419 (38%)\n\n\n\n\nHospital Teaching Status\n\n\n\n\n\n\n0.8\n\n\n    Metropolitan, non-teaching\n4,717 (21%)\n4,479 (21%)\n238 (22%)\n\n\n\n\n    Metropolitan, teaching\n16,918 (74%)\n16,110 (74%)\n808 (73%)\n\n\n\n\n    Non-metropolitan\n1,143 (5.0%)\n1,086 (5.0%)\n57 (5.2%)\n\n\n\n\nInsurance\n\n\n\n\n\n\n0.019\n\n\n    Private\n4,896 (22%)\n4,694 (22%)\n202 (18%)\n\n\n\n\n    Medicaid\n1,963 (8.6%)\n1,868 (8.6%)\n95 (8.6%)\n\n\n\n\n    Medicare\n14,287 (63%)\n13,531 (63%)\n756 (68%)\n\n\n\n\n    Other\n1,600 (7.0%)\n1,550 (7.2%)\n50 (4.6%)\n\n\n\n\nNo. of comorbidities\n\n\n\n\n\n\n&lt;0.001\n\n\n    One comorbidity\n2,402 (11%)\n2,349 (11%)\n53 (4.8%)\n\n\n\n\n    Two or more comorbidities\n20,377 (89%)\n19,326 (89%)\n1,051 (95%)\n\n\n\n\nHypertension\n10,463 (46%)\n10,015 (46%)\n448 (41%)\n0.014\n\n\nDiabetes\n7,335 (32%)\n6,940 (32%)\n395 (36%)\n0.10\n\n\nHyperlipidemia\n12,917 (57%)\n12,251 (57%)\n666 (60%)\n0.10\n\n\nChronic kidney disease\n6,788 (30%)\n6,373 (29%)\n415 (38%)\n&lt;0.001\n\n\nCoronary artery disease\n18,131 (80%)\n17,178 (79%)\n953 (86%)\n&lt;0.001\n\n\nAnemia\n9,549 (42%)\n8,993 (41%)\n556 (50%)\n&lt;0.001\n\n\nHeart failure\n13,759 (60%)\n12,970 (60%)\n789 (71%)\n&lt;0.001\n\n\nAIDS/HIV\n42 (0.2%)\n38 (0.2%)\n4 (0.4%)\n0.2\n\n\nAlcohol abuse\n1,022 (4.5%)\n965 (4.5%)\n57 (5.1%)\n0.4\n\n\nDrug abuse\n830 (3.6%)\n782 (3.6%)\n48 (4.3%)\n0.4\n\n\nDepression\n1,741 (7.6%)\n1,612 (7.4%)\n129 (12%)\n&lt;0.001\n\n\nValvular Disease\n4,673 (21%)\n4,398 (20%)\n275 (25%)\n0.019\n\n\nChronic pulmonary disease\n5,370 (24%)\n5,066 (23%)\n304 (28%)\n0.040\n\n\nRheumatic Disease\n443 (1.9%)\n406 (1.9%)\n36 (3.3%)\n0.033\n\n\nMetastatic Cancer\n238 (1.0%)\n232 (1.1%)\n6 (0.6%)\n0.2\n\n\nLymphoma\n119 (0.5%)\n112 (0.5%)\n7 (0.6%)\n0.7\n\n\nObesity\n3,643 (16%)\n3,450 (16%)\n192 (17%)\n0.4\n\n\nHypothyroidism\n2,586 (11%)\n2,480 (11%)\n106 (9.6%)\n0.2\n\n\nFluid and electrolyte disorders\n13,024 (57%)\n12,384 (57%)\n640 (58%)\n0.7\n\n\nPeptic ulcer disease\n295 (1.3%)\n265 (1.2%)\n29 (2.7%)\n0.028\n\n\nCerebrovascular Disease\n2,057 (9.0%)\n1,946 (9.0%)\n111 (10%)\n0.4\n\n\nPeripheral vascular disease\n3,950 (17%)\n3,727 (17%)\n223 (20%)\n0.073\n\n\nCoagulopathy\n4,648 (20%)\n4,441 (20%)\n207 (19%)\n0.3\n\n\n\n1 n (%)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes of Index Hospitalizations\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 22,7791\nWithout Readmission\nN = 21,6751\nWith 30-day readmission\nN = 1,1041\np-value2\n\n\n\n\nIn-Hospital Mortality\n7,789 (34%)\n7,789 (36%)\n0 (0%)\n&lt;0.001\n\n\nLength of Stay (days)\n7 (3, 12)\n6 (3, 12)\n10 (6, 18)\n&lt;0.001\n\n\nInflation-Adjusted Total Charges ($)\n149,614 (80,930, 278,080)\n147,394 (79,607, 273,624)\n198,365 (110,143, 370,149)\n&lt;0.001\n\n\nDischarged to Non-Home Setting\n12,816 (56%)\n12,355 (57%)\n460 (42%)\n&lt;0.001\n\n\nUndergoing CABG\n4,057 (18%)\n3,792 (17%)\n265 (24%)\n&lt;0.001\n\n\nUndergoing PCI\n12,898 (57%)\n12,241 (56%)\n657 (59%)\n0.2\n\n\nMechanical Ventilation\n10,380 (46%)\n9,966 (46%)\n414 (37%)\n&lt;0.001\n\n\nVenous thromboembolism\n962 (4.2%)\n915 (4.2%)\n46 (4.2%)\n&gt;0.9\n\n\nStroke\n1,374 (6.0%)\n1,314 (6.1%)\n60 (5.5%)\n0.6\n\n\nSepsis\n2,370 (10%)\n2,255 (10%)\n115 (10%)\n&gt;0.9\n\n\nAcuteKidneyInjury\n11,528 (51%)\n10,962 (51%)\n566 (51%)\n0.8\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#readmission-hospitalization-characteristics",
    "href": "quarto/index.html#readmission-hospitalization-characteristics",
    "title": "Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock",
    "section": "Readmission Hospitalization Characteristics",
    "text": "Readmission Hospitalization Characteristics\n\nResource Utilization During Readmission\nReadmission hospitalizations resulted in:\n\nMedian Length of Stay (IQR), days: 4 (IQR: 2–8)\nMedian Total Charges (IQR): $40,339 (IQR: $19,984–$88,325)"
  },
  {
    "objectID": "quarto/index.html#multivariable-analyses",
    "href": "quarto/index.html#multivariable-analyses",
    "title": "Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock",
    "section": "Multivariable Analyses",
    "text": "Multivariable Analyses\n\n30-Day Readmission:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nAge (years)\n\n\n\n\n\n\n\n\n    18–49\n—\n—\n\n\n\n\n    50–64\n0.89\n0.60, 1.32\n0.6\n\n\n    65–79\n0.99\n0.64, 1.53\n&gt;0.9\n\n\n    80+\n0.96\n0.60, 1.56\n0.9\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n1.18\n0.96, 1.46\n0.12\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.03\n0.70, 1.51\n0.9\n\n\n    Medicare\n1.29\n0.94, 1.78\n0.12\n\n\n    Other\n0.80\n0.50, 1.26\n0.3\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n0.91\n0.70, 1.18\n0.5\n\n\n    51st to 75th percentile\n0.78\n0.60, 1.01\n0.060\n\n\n    76th to 100th percentile\n0.93\n0.71, 1.21\n0.6\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n0.82\n0.60, 1.13\n0.2\n\n\n    Medium\n0.88\n0.63, 1.21\n0.4\n\n\nHospital Urbanization\n\n\n\n\n\n\n\n\n    Large metropolitan ≥1 million\n—\n—\n\n\n\n\n    Micropolitan\n0.95\n0.58, 1.54\n0.8\n\n\n    Non-urban\n0.49\n0.08, 2.87\n0.4\n\n\n    Small metropolitan &lt;1 million\n0.82\n0.66, 1.01\n0.066\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n0.85\n0.68, 1.05\n0.14\n\n\nDischarged to Non-Home Setting\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.47\n0.39, 0.57\n&lt;0.001\n\n\nNo. of comorbidities\n\n\n\n\n\n\n\n\n    One comorbidity\n—\n—\n\n\n\n\n    Two or more comorbidities\n1.52\n0.96, 2.43\n0.075\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.67, 0.99\n0.038\n\n\nDiabetes\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.13\n0.92, 1.40\n0.2\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.82, 1.23\n&gt;0.9\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n1.04, 1.55\n0.018\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.42\n1.11, 1.81\n0.005\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.25\n1.03, 1.52\n0.022\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.30\n1.02, 1.66\n0.031\n\n\nAIDS/HIV\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.36\n0.34, 5.44\n0.7\n\n\nAlcohol abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n0.81, 1.91\n0.3\n\n\nDrug abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n0.74, 1.84\n0.5\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n0.98, 1.83\n0.064\n\n\nValvular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n0.85, 1.34\n0.6\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n0.85, 1.33\n0.6\n\n\nRheumatic Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.60\n0.91, 2.80\n0.10\n\n\nMetastatic Cancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.20, 1.50\n0.2\n\n\nLymphoma\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.17\n0.33, 4.18\n0.8\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n0.82, 1.36\n0.7\n\n\nHypothyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.56, 1.00\n0.050\n\n\nFluid and electrolyte disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.83, 1.22\n&gt;0.9\n\n\nPeptic ulcer disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.16\n1.02, 4.56\n0.044\n\n\nCerebrovascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n0.84, 1.54\n0.4\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.87, 1.35\n0.5\n\n\nCoagulopathy\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.62, 1.01\n0.061\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  }
]